Study uncovers vast genomic diversity in Aboriginal Australian communities

Study on Aboriginal Australian communities using whole-genome sequencing reveals a high level of unique genetic diversity, including novel alleles and structural variants, crucial for understanding human genomic evolution and medical genetics.

Immunic Reports Positive Interim Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis – Biotech Investments

Issuer: Immunic, Inc. / Key word(s): Study results 09.10.2023 / 22:01 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic Reports

October 10, 2023

The biotech scoreboard for the second quarter: 32 stock-moving events to watch

Here is STAT’s biotech scoreboard, our regular ledger of stock-moving biotech events, for the second quarter and middle of the year: Obesity catalysts, first. advertisement

April 2, 2024

Ajinomoto signs agreement to acquire Forge for $620m

Forge carries out its development and production activities at its 200,000ft ² cGMP facility in Columbus, Ohio, US. Credit: metamorworks / Shutterstock.com. Ajinomoto has signed

November 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.